Tuesday, 29 April 2025
27.5 C
Singapore
28.3 C
Thailand
19.9 C
Indonesia
28.3 C
Philippines

Bioptimus embarks on a revolutionary AI journey in biology with US$35 million funding

Bioptimus, a Paris-based AI startup with a US$35 million seed round, is trailblazing in biology, aiming to transform healthcare with AI.

You are entering a realm where biology and artificial intelligence converge, brought to life by Bioptimus, an emerging generative AI startup based in Paris. This venture stands out with its razor-sharp focus on biology, applying the latest AI advancements exclusively to this vital scientific arena. Bioptimus isn’t just another AI company; it’s a pioneer, charting a course in unexplored territories of biological research.

Tackling the challenge of sensitive data

Imagine the complexities of training AI models in a domain where every piece of data is not just complex but shrouded in layers of confidentiality. This is the challenge Bioptimus embraces head-on. Diverging from the path of companies like OpenAI, which are gravitating towards content licensing, Bioptimus is navigating the intricate landscape of clinical data, a domain typically hidden from public scrutiny. This unique challenge underscores the groundbreaking nature of their work.

Furthermore, Bioptimus faces the high costs associated with AI development. Training sophisticated AI models demands state-of-the-art GPUs and a team of highly skilled researchers. Bioptimus has successfully raised an impressive US$35 million in seed funding to meet these demands. Sofinnova Partners spearhead this round and includes investments from an array of notable entities such as Bpifrance’s Large Venture fund, Frst, Cathay Innovation, Headline, Hummingbird, NJF Capital, Owkin, Top Harvest Capital, and Xavier Niel.

Visionary leadership and collaborative synergy

Guiding Bioptimus is Jean-Philippe Vert, who takes on the roles of co-founder and executive chairman while concurrently serving as the Chief R&D Officer at Owkin, a French biotech unicorn. The team’s technological expertise is bolstered by Rodolphe Jenatton, the CTO, who brings valuable experience from his tenure as a senior research scientist at Google. Complementing this leadership are several ex-researchers from Google DeepMind.

Bioptimus’s approach is further enhanced through a strategic partnership with Owkin. Utilising Owkin’s extensive multimodal patient data, collected through collaborations with top academic hospitals worldwide, Bioptimus has access to a diverse and rich dataset for training its foundational model. This synergy marks a unique collaboration, leveraging existing resources for groundbreaking research.

A strategic spin-off with a focused mission

Bioptimus can be viewed as a strategic offshoot of Owkin, conceived as a moonshot project. The daunting task of creating new AI models in biology necessitated the formation of a distinct entity, allowing for a more concentrated and practical approach. Vert explains that while building foundational biology models is not on Owkin’s immediate agenda, the partnership with Bioptimus aligns with their long-term vision, providing the necessary resources and specialisation for this ambitious undertaking.

A partnership with Amazon Web Services signifies Bioptimus’s commitment to utilising top-tier resources for its model training, leveraging Amazon’s advanced data centres. The implications of Bioptimus’s work are far-reaching. The AI models they develop are poised to transform disease diagnosis and precision medicine and lead to the discovery of new biomolecules for both medical and environmental applications.

In summary, Bioptimus represents a bold step into the future of biotechnology. It’s not just about launching a new company; it’s about reshaping the landscape of healthcare and environmental science through the innovative application of AI in biology.

Hot this week

AMD optimizes models for faster generative AI performance with Amuse 3.0

AMD announces optimised models for faster AI performance with Amuse 3.0, featuring enhanced photo filters, video diffusion, and more.

XPENG unveils AI-powered innovations and supercharged EVs at Auto Shanghai 2025

XPENG launches AI brain, 10-minute charging EV, and IRON humanoid robot at Auto Shanghai 2025, setting new mobility benchmarks.

Intel prepares for major layoffs ahead of Q1 earnings

Intel plans to cut over 21,000 jobs this week, aiming to rebuild its focus and engineering culture under new CEO Lip-Bu Tan.

WhatsApp adds new Advanced Chat Privacy feature to boost group chat security

WhatsApp's new Advanced Chat Privacy feature helps stop group chat content from being shared or saved outside the app.

xAI’s Grok chatbot now lets you ask questions about what you see

Grok’s new Vision tool lets iPhone users ask questions about what they see. Updates also add real-time voice search and memory features.

Razer Launches Pro Click V2 and V2 Vertical Mice: Blending Gaming and Productivity

Razer's new Pro Click V2 and V2 Vertical mice offer gaming precision and ergonomic comfort, with AI prompt access and long battery life, available now!

Nintendo Pop-Up Store and Mario Kart Fun Return to Jewel Changi Airport

Experience the magic of Nintendo at Jewel Changi Airport with the return of the Pop-Up Store and the exciting Mario Kart Jewel Circuit Challenge!

Lian Li’s new Lancool 207 Digital case brings a 6-inch LCD screen to your PC

Lian Li's Lancool 207 Digital PC case brings a bright 6-inch LCD screen to your setup, offering style, function, and full customisation.

Google to end support for early Nest thermostats on October 25

Google will stop supporting first—and second-generation Nest thermostats on October 25 and end new Nest launches in Europe.

Related Articles

Popular Categories